Smart Pills Market Size In 2026: Growth Outlook And Forecast Through 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Smart Pills Market Forecast: Value Set To Climb From $6.75 Billion To $10.13 Billion
The smart pills market has observed significant expansion in recent years. It is anticipated to increase from $6.11 billion in 2025 to $6.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.5%. This historic growth is largely due to the increasing incidence of chronic conditions, the growing demand for patient compliance oversight, the expansion of digital health programs, the availability of sophisticated ingestible sensors, and the rising uptake of clinical research.
The smart pills market is projected to experience substantial expansion over the next few years, reaching $10.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. This anticipated growth during the forecast period is primarily driven by the increasing demand for personalized medicine solutions, a rise in investments in digital therapeutics, the ongoing expansion of remote patient monitoring, the growing adoption of smart drug delivery platforms, and increasing regulatory support for connected health technologies. Significant trends for the forecast period include the increasing adoption of sensor-enabled drug delivery systems, a rising focus on medication adherence solutions, growing integration with mobile health platforms, the expansion of smart ingestible diagnostics, and enhanced development of miniaturized electronics.
Get A Free Sample Report With In-Depth Market Insights:
Smart Pills Market Demand Drivers Opening New Revenue Streams
The increasing preference for non-invasive procedures is expected to propel the growth of the smart pills market going forward. These procedures avoid incisions or tissue removal, thereby reducing patient risk and recovery time. The growing preference for non-invasive procedures is attributed to their ability to deliver effective diagnostic and therapeutic outcomes while minimizing physical burden on patients. Smart pills support non-invasive procedures by enabling internal imaging and physiological monitoring without surgical entry, allowing clinicians to gather diagnostic data through a simple swallowable device. For instance, in March 2024, according to NHS England, a UK-based public health service, more than 5,400 patients benefited from colon capsule endoscopy pill-cam pilots across 53 sites. Therefore, the growing preference for non-invasive procedures is driving the smart pills market.
Smart Pills Market Driver: Growing Healthcare Expenditure Fueling The Growth Of The Market Due To Increasing Investment In Long-Term Mental Health Treatments
The rising healthcare expenditure is anticipated to drive the smart pills market’s expansion in the future. Healthcare expenditure refers to the total financial amount spent on medical services, treatments, facilities, research, and public health initiatives to maintain or improve health outcomes. The increasing demand for healthcare spending stems from the rising prevalence of chronic mental health conditions, which necessitate continuous treatment, medication, and long-term care support. Healthcare expenditure supports the development of smart pills by funding advanced technologies that enhance drug delivery, monitoring, and patient adherence. For instance, in December 2024, according to the Centers for Medicare and Medicaid Services (CMS), a US-based federal agency, the national health expenditures (NHE) grew by 7.5% to $4.9 trillion in 2023, accounting for 17.6% of gross domestic product (GDP). Additionally, between 2023 and 2032, average national health expenditures (NHE) are projected to grow at an average annual rate of 5.6%, resulting in an increase in the health spending share of gross domestic product (GDP) from 17.3% in 2022 to 19.7% in 2032. Therefore, the growing healthcare expenditure is driving the growth of the smart pills market.
Smart Pills Market Segment Landscape And Growth Outlook
The smart pills market covered in this report is segmented –
1) By Target Area: Esophagus, Stomach, Small Intestine, Large Intestine
2) By Disease Indication: Esophageal Diseases, Colon Diseases, Small bowel Diseases, And Other Disease Indications
3) By Application: Capsule Endoscopy, Patient Monitoring, Drug Delivery
4) By End User: Hospital, Diagnostic Center, Research Institute
Subsegments:
1) By Esophagus: Diagnostic Pills For Esophageal Disorders, Pills For Monitoring Esophageal Motility
2) By Stomach: Gastric Emptying Monitoring Pills, Diagnostic Pills For Gastric Disorders
3) By Small Intestine: Pills For Absorption Studies, Diagnostic Pills For Small Bowel Diseases
4) By Large Intestine: Colonoscopy Alternative Pills, Pills For Detecting Colorectal Disorders
Smart Pills Market Trends Powering Strategic Industry Growth
Leading companies in the smart pills market are concentrating on creating smart pills that feature configurable programs, such as ingestible, multi-sensor prototypes designed to enable personalized drug delivery and internal monitoring, with the goal of improving patient adherence to treatment and overall therapeutic results. Configurable programs are defined as the software or firmware-driven management of sensing, data collection, and activatable actions, which medical professionals or study administrators can customize for individual patients. For example, in 2025, Interuniversity Microelectronics Centre, a research and innovation institute based in Belgium, launched a prototype ingestible sensor for monitoring gut health. This sensor incorporates various sensing methods (chemical, mechanical, and electrical), integrated signal processing and power management, and real-time data transmission for remote oversight; the prototype highlights its compact size and comprehensive system integration to support adaptable sensing programs for tailored clinical application.
Smart Pills Market Top Companies Driving Competitive Growth
Major companies operating in the smart pills market are Medtronic plc, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.
View The Full Smart Pills Market Report:
Smart Pills Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the smart pills market in 2025. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
